ReviewCureus2020
Understanding the Fight Against Resistance: Hospital-Acquired Methicillin-Resistant Staphylococcus Aureus vs. Community-Acquired Methicillin-Resistant Staphylococcus Aureus.
Review in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 42 citations in OpenAlex.
- The global epidemiology of MRSA.JAC-antimicrobial resistance · 2026Review
- Article
- Neonatal Osteomyelitis Caused byChildren (Basel, Switzerland) · 2026Review
- Staphylococcal Cassette ChromosomeAntibiotics (Basel, Switzerland) · 2026Article
- Treatment of Methicillin-ResistantMedicines (Basel, Switzerland) · 2026Review
- Antimicrobial resistance patterns of Staphylococcus aureus isolates in tertiary hospital in Somalia: a retrospective study.BMC infectious diseases · 2026Article
- Pathoadaptive evolution and clonal dissemination of community- associated methicillin-resistant Staphylococcus aureus in Egypt.BMC infectious diseases · 2026Article
- Preventable Infectious Pathology Dominates Neonatal Readmissions: A Retrospective Analysis from a Pediatrics Department in Ploiești, Romania.Children (Basel, Switzerland) · 2026Article
- Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) in acute and chronic sinusitis.Molecular biology reports · 2025Article
- Epidemiology, Virulence Factors, and Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2025Article
- Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits - a comprehensive review.Frontiers in immunology · 2025Review
- Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic.Antibiotics (Basel, Switzerland) · 2024Article
- Phenotypic and genotypic characteristics of mecA - positive oxacillin-sensitive Staphylococcus aureus isolated from patients with bloodstream infection in a tertiary hospital in Southern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Methicillin-resistantVeterinary world · 2024Review
- Time-calibrated phylogenetic and chromosomal mobilome analyses of Staphylococcus aureus CC398 reveal geographical and host-related evolution.Nature communications · 2024Article
- Article
- Genome mining of Lactiplantibacillus plantarum PA21: insights into its antimicrobial potential.BMC genomics · 2024Article
- Antibiotic susceptibility patterns at the Médecins Sans Frontières (MSF) Acute Trauma Hospital in Aden, Yemen: a retrospective study from January 2018 to June 2021.JAC-antimicrobial resistance · 2024Article
- Deriving Novel Quaternary Ammonium Compound Disinfectant Scaffolds from a Natural Product: Mechanistic Insights of the Quaternization of Ianthelliformisamine C.ChemMedChem · 2023Article
- Preparation and characterization of spiked gold nanobipyramids and its antibacterial effect on methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus.Journal, genetic engineering & biotechnology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the identification of Staphylococcus (S.) aureus, penicillin was exclusively used to combat its disastrous toxic effects. Shortly thereafter, resistant strains arose, which were no longer susceptible to penicillin or methicillin treatments. These strands were later identified as methicillin-resistant Staphylococcus aureus (MRSA). Two particular MRSA strands that are discussed below are the hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) strands and the community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strands. Despite arising from a single bacterium, S. aureus, each of these two strands possesses quite different resistance and virulence factors. These differences contribute to the type of population in which they affect, their ability to resist traditional treatment approaches, and their overall morbidity and mortality rates. We explore these differences by reviewing several review articles published on various reputable scientific online databases. Findings include sources from studies conducted in the United States, China, Nepal, and Uganda, ranging from 2006 to 2019. These resistance and virulence factors, the Staphylococcal cassette cartridge mecA resistance gene (SCCmec) and the Panton-Valentine Leukocidin toxin gene (PVL), were identified and isolated in each of these studies in order to appreciate similarities and differences in how they impact human beings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.